Ocular Therapeutix's drug delivery system
GPTKB entity
Properties (69)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug delivery system
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:designedFor |
ophthalmic conditions
|
| gptkbp:developedBy |
gptkb:Ocular_Therapeutix,_Inc.
|
| gptkbp:hasCollaboratedWith |
research institutions
clinical researchers healthcare_organizations |
| https://www.w3.org/2000/01/rdf-schema#label |
Ocular Therapeutix's drug delivery system
|
| gptkbp:improves |
patient compliance
|
| gptkbp:includes |
Dextenza
|
| gptkbp:isAttendedBy |
punctum plug
|
| gptkbp:isAvailableIn |
gptkb:the_United_States
|
| gptkbp:isBasedOn |
biodegradable polymer technology
|
| gptkbp:isCitedIn |
various studies
|
| gptkbp:isDesignedFor |
improve quality of life
facilitate healing enhance drug absorption enhance therapeutic outcomes minimize side effects reduce treatment burden |
| gptkbp:isEvaluatedBy |
cost-effectiveness
patient satisfaction patient adherence long-term effects clinical effectiveness safety and effectiveness |
| gptkbp:isFocusedOn |
improving patient outcomes
|
| gptkbp:isIntegratedWith |
patients undergoing eye surgery
|
| gptkbp:isMarketedAs |
healthcare_providers
Dextenza_for_ocular_surgery |
| gptkbp:isPartOf |
Ocular_Therapeutix_product_line
Ocular_Therapeutix's_commercialization_strategy Ocular_Therapeutix's_future_developments Ocular_Therapeutix's_innovations Ocular_Therapeutix's_offerings Ocular_Therapeutix's_pipeline Ocular_Therapeutix's_research_initiatives Ocular_Therapeutix's_strategy |
| gptkbp:isPromotedThrough |
medical conferences
|
| gptkbp:isRecognizedFor |
its convenience
its innovative approach its efficacy its safety profile its patient-centric design its role in advancing ophthalmic care |
| gptkbp:isRegulatedBy |
health authorities
|
| gptkbp:isSupportedBy |
investors
clinical data clinical guidelines scientific research |
| gptkbp:isTargetedAt |
chronic eye conditions
|
| gptkbp:isTestedFor |
safety in diverse populations
various ocular conditions |
| gptkbp:isTrainedIn |
clinical trials
real-world settings |
| gptkbp:isUsedIn |
eye surgeries
|
| gptkbp:isUtilizedFor |
pain management
ophthalmologists |
| gptkbp:isUtilizedIn |
clinical practice
drug formulation post-operative care ophthalmology |
| gptkbp:isVisitedBy |
patient feedback
sustained ocular drug delivery |
| gptkbp:provides |
extended duration of drug release
|
| gptkbp:reduces |
need for topical medications
|
| gptkbp:targets |
inflammation
post-surgical pain |
| gptkbp:uses |
sustained release technology
|